Reduction of tumor necrosis factor (TNF) in milk of women receiving anti-TNF antibody

被引:1
作者
Sepiashvili, Lusia [1 ,2 ]
Brydon, Avery [3 ]
Koroshegyi, Christine [4 ]
Gold, Anna [4 ]
Dalvi, Pooja [5 ,6 ]
Ghayoori, Sholeh [5 ,6 ]
Rahman, Mehzabin [5 ,6 ]
Huang, Vivian [7 ,8 ]
Maxwell, Cynthia [9 ,10 ]
Nguyen, Geoffrey C. [7 ,11 ,12 ]
Ito, Shinya [3 ,5 ,6 ]
机构
[1] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[3] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[4] Hosp Sick Children, Dept Psychol, Toronto, ON, Canada
[5] Hosp Sick Children, Dept Paediat, Div Clin Pharmacol & Toxicol, Toronto, ON, Canada
[6] Hosp Sick Children, Res Inst, Translat Med Program, Toronto, ON, Canada
[7] Mt Sinai Hosp, Div Gastroenterol, Toronto, ON, Canada
[8] Univ Toronto, Div Gastroenterol & Hepatol, Toronto, ON, Canada
[9] Womens Coll Hosp, Dept Gynecol, Toronto, ON, Canada
[10] Mt Sinai Hosp, Dept Obstet & Gynecol, Toronto, ON, Canada
[11] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[12] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
INFLAMMATORY-BOWEL-DISEASE; CYTOKINES; ALPHA;
D O I
10.1038/s41390-024-03672-9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundTumor Necrosis Factor (TNF) are expressed in milk. Experimental data indicate enhanced brain growth and cognitive development in the mouse offspring given milk deficient in TNF and TNF-dependent chemokines. Although monoclonal antibodies against TNF (TNFmAb) are used during breastfeeding due to minimal milk excretion, whether it affects endogenous TNF levels in human milk is unclear.MethodsA prospective cohort study was conducted in 26 breastfeeding women with inflammatory bowel disease (IBD) and 31 non-IBD women. Milk TNF and related chemokines were measured at 5-6 weeks postpartum (early-lactation point) as a primary endpoint and further determined at 13-14 weeks postpartum. In a subset of their infants, neurocognitive development was assessed at 12 and 18 months of age using Bayley-III tool.ResultsWhile milk TNF levels were not significantly different between the control and those with IBD, women with IBD receiving TNFmAb showed 70% lower median milk TNF than those without TNFmAb (P = 0.019) at early lactation period. TNF-dependent chemokines (MIP-1 beta and IP-10) also showed similar patterns. Neurocognitive development of the infants was not significantly different among the groups.ConclusionsWomen with IBD receiving TNFmAb show significantly lower milk TNF/chemokines at 5-6 weeks postpartum than those without TNFmAb. Clinicaltrials.gov NCT03397108.ImpactWe found that milk concentrations of Tumor Necrosis Factor (TNF) and TNF-dependent chemokines (MIP-1 beta and IP-10) are low in women with inflammatory bowel disease who are receiving anti-TNF monoclonal antibody (TNFmAb), compared to those without concurrent anti TNF therapy.While maternal use of TNFmAb during breastfeeding is considered inconsequential to infant health due to their low levels of milk excretion, it affects profiles of endogenous cytokines in milk.Our findings provide a rationale to investigate human implications of the animal data in the literature that suggest enhancement of neurocognitive development of the offspring fed with milk deficient in TNF-dependent chemokines.
引用
收藏
页码:1935 / 1942
页数:8
相关论文
共 33 条
[1]   Transfer of proinflammatory cytokines across term placenta [J].
Aaltonen, R ;
Heikkinen, TA ;
Hakala, K ;
Laine, K ;
Alanen, A .
OBSTETRICS AND GYNECOLOGY, 2005, 106 (04) :802-807
[2]   Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology [J].
Baumgart, Daniel C. ;
Carding, Simon R. .
LANCET, 2007, 369 (9573) :1627-1640
[3]  
BAYLEY N, 1993, BAYLEY SCALES INFANT
[4]   Premature Delivery Influences the Immunological Composition of Colostrum and Transitional and Mature Human Milk [J].
Castellote, Cristina ;
Casillas, Rosario ;
Ramirez-Santana, Carolina ;
Perez-Cano, Francisco J. ;
Castell, Margarida ;
Gloria Moretones, M. ;
Carmen Lopez-Sabater, M. ;
Franch, Angels .
JOURNAL OF NUTRITION, 2011, 141 (06) :1181-1187
[5]   Cytokines and Soluble Receptors in Breast Milk as Enhancers of Oral Tolerance Development [J].
Dawod, Bassel ;
Marshall, Jean S. .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[6]   Quality control, analysis and secure sharing of Luminex® immunoassay data using the open source LabKey Server platform [J].
Eckels, Josh ;
Nathe, Cory ;
Nelson, Elizabeth K. ;
Shoemaker, Sara G. ;
Van Nostrand, Elizabeth ;
Yates, Nicole L. ;
Ashley, Vicki C. ;
Harris, Linda J. ;
Bollenbeck, Mark ;
Fong, Youyi ;
Tomaras, Georgia D. ;
Piehler, Britt .
BMC BIOINFORMATICS, 2013, 14
[7]   Infliximab and Adalimumab Use During Breastfeeding [J].
Fritzsche, Juliane ;
Pilch, Anna ;
Mury, Dina ;
Schaefer, Christof ;
Weber-Schoendorfer, Corinna .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (08) :718-719
[8]   Cytokines in Human Milk [J].
Garofalo, Roberto .
JOURNAL OF PEDIATRICS, 2010, 156 (02) :S36-S40
[9]  
HARVEY RF, 1980, LANCET, V1, P514
[10]   Cytokine production by human milk cells and peripheral blood mononuclear cells from the same mothers [J].
Hawkes, JS ;
Bryan, DL ;
Gibson, RA .
JOURNAL OF CLINICAL IMMUNOLOGY, 2002, 22 (06) :338-344